TY - JOUR
T1 - Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease :
T2 - A Nationwide Study With Propensity-Matched Score Analysis
AU - Cañete, Fiorella
AU - Mañosa i Ciria, Míriam
AU - Pérez-Martínez, Isabel
AU - Barreiro de-Acosta, Manuel
AU - González-Sueyro, Ramiro C.
AU - Nos, Pilar
AU - Iglesias-Flores, Eva
AU - Gutiérrez Casbas, Ana
AU - Bujanda, Luis
AU - Gordillo, Jordi
AU - Ríos León, Raquel
AU - Casanova, María José
AU - Villoria, Albert
AU - Rodríguez-Lago, Iago
AU - López Serrano, Pilar
AU - García-Herola, Antonio
AU - Ramírez-de la Piscina, Patricia
AU - Navarro-Llavat, Mercè
AU - Taxonera, Carlos
AU - Barrio, Jesús
AU - Ramos López, Laura
AU - Navarro, Pablo
AU - Benítez-Leiva, Olga
AU - Calafat, Margalida
AU - Domènech, Eugeni
PY - 2020
Y1 - 2020
N2 - Patients with Crohn's disease experiencing endoscopic postoperative recurrence (POR) may benefit from antitumor necrosis factor (TNF) agents but scarce data on this are available. Our aim was to assess the efficacy of anti-TNF in improving mucosal lesions in patients with endoscopic POR. Multicenter, retrospective, study of patients with Crohn's disease who underwent therapy with anti-TNF agents for endoscopic POR (Rutgeerts score
AB - Patients with Crohn's disease experiencing endoscopic postoperative recurrence (POR) may benefit from antitumor necrosis factor (TNF) agents but scarce data on this are available. Our aim was to assess the efficacy of anti-TNF in improving mucosal lesions in patients with endoscopic POR. Multicenter, retrospective, study of patients with Crohn's disease who underwent therapy with anti-TNF agents for endoscopic POR (Rutgeerts score
UR - https://www.scopus.com/pages/publications/85091470114
U2 - 10.14309/ctg.0000000000000218
DO - 10.14309/ctg.0000000000000218
M3 - Article
C2 - 32955190
SN - 2155-384X
VL - 11
JO - Clinical and Translational Gastroenterology
JF - Clinical and Translational Gastroenterology
ER -